Sign in to view Jodi’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Sign in to view Jodi’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Greater Lynchburg Area
Sign in to view Jodi’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
5K followers
500+ connections
Sign in to view Jodi’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
View mutual connections with Jodi
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
View mutual connections with Jodi
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Sign in to view Jodi’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
View Jodi’s full profile
-
See who you know in common
-
Get introduced
-
Contact Jodi directly
Other similar profiles
Explore more posts
-
Sean Smith
Search Fund Ventures • 7K followers
For small business buyers, how important is industry experience? I discussed this topic with Lisa Piercey—physician-turned-operator, former Tennessee Commissioner of Health, and now a healthcare acquirer. The key takeaway: It can be the difference between generating alpha and facing unpleasant surprises post-close. Below are some of the other topics we discussed: 1️⃣ Credibility wins deals. Not just with employees and customers—with sellers. 2️⃣ Beware "unknown unknowns." Buying outside your domain? Mitigate with true subject-matter experts. 3️⃣ Use a "tight, loose, tight" thesis framework. Define the buy box clearly, stay open minded in the middle, then apply a binary filter: in the buy box or not. 4️⃣ When deals wobble, get creative. One of Lisa's best examples: a contract CEO + call option structure to bridge a diligence gap and flatten the post-close learning curve. Lisa also wrote Natural Born Entrepreneurs for mid-career professionals considering ETA, packed with templates, checklists, and an honest look at the tradeoffs vs. a W-2 path. If you're underwriting operators, or searching yourself, this one's worth a listen. Watch here: https://lnkd.in/dadEJ7WZ Listen here: https://lnkd.in/dm2sAG9v
26
2 Comments -
Lisa Piercey
Oakworth Capital Bank • 4K followers
FORCING CHANGE IN SITE OF CARE McKinsey & Company's recent paper on the forces pressuring healthcare, including the possibility of margin compression of up to 13 percentage points for health systems, does a good job of putting numbers around what most operators already feel. Two of the biggest drivers they mention are policy shifts in reimbursement and rising utilization driven by an aging population. The cohort of 70+ year old Americans will grow the fastest over the next 5 years, and it is well established that older patients have more complex needs, more chronic disease, and more touchpoints within the healthcare system. Layer that on top of continued clinical workforce shortages, and the supply-demand gap widens further. From my perspective, optimizing for site of care is the most important lever we have to address this challenge. We can’t quickly reduce how much care older patients need, but we can change where and how services are delivered. Supporting aging patients in lower-cost settings like the home, ambulatory sites, and virtual environments is no longer just a preference or convenience, it’s a necessity. This is where the conversation around site-neutral payments becomes so relevant. CMS is moving quickly in this direction, and hospital outpatient departments (HOPDs) are squarely in the crosshairs. The shift will undoubtedly clamp down further on hospital margins, but it shouldn’t be surprising. We’ve been talking about the demise of HOPD reimbursement for years, and the health systems that will fare best are the ones who are working towards aligning their approach with where patients can be treated safely, efficiently, and at lower cost, rather than relying on legacy reimbursement structures to fill the gap. And just like it doesn’t make sense to try to replicate a hospital or nursing home environment in a patient’s home, we also shouldn’t try to carry the same clinical staffing model into every care setting. Yes, there are non-negotiables when it comes to patient safety and clinical expertise, but there’s also a meaningful opportunity to rethink how teams are built. That means clinicians at every level working at the top of their licenses, thoughtfully involving family members and community resources, and using technology to surround these sites of care with non-clinical operational support. From my health system days, I understand why rising costs, margin pressure, and site-neutral payments feel like threats. While painful, I’m hopeful they can also serve as a positive forcing function, pushing us toward care models that are better aligned with our aging population and the realities of today’s workforce.
23
1 Comment -
Stephen Krupa
HealthEdge • 3K followers
HealthEdge recently released its fifth annual Healthcare Consumer Report, unveiling key insights into consumer sentiment about their health insurance plans. This research was conducted through a survey of more than 4,500 health plan members in the U.S. in May 2025. This year’s findings highlight the growing importance of affordability, transparency, member engagement, and the role of emerging technologies like artificial intelligence (AI) in shaping consumer expectations. The research sends a clear message: health plans that act as true partners in care, not just processors of claims, are rewarded with higher trust, stronger satisfaction, and greater member loyalty. Consumers are no longer content with transactional interactions. They expect digital ease, personalized support, and meaningful engagement throughout their health journey. Health plans must evolve their operating models to meet these expectations and drive better outcomes at scale. Read the full report here: https://lnkd.in/e7Fh2a_B
66
2 Comments -
Leah Glover Hayes
Claritas Capital • 7K followers
Interesting conversation this morning with Nashville Business Journal on the #HealthCareoftheFuture with Derek Dedeker Fahad Tahir Lee Ann Liska James E.K. Hildreth Julie Honey, DNP, APRN, CPNP-PC, FNP-C. Major concern: ✂️ Federal cuts are being done with a machete instead of a scalpel and will most impact: 🩺 current patient care and widen the care gap of our most vulnerable 🐌 Slow the future of our innovation in developing breakthroughs in procedures and treatments. Opportunity: 📊 30% of all data world wide is created from healthcare… With AI and technology advancements happening today we are on the precipous of healthcare transformation that will shape the future of care. #healthcare #healthcareinnovation
14
1 Comment -
Global Corporate Venturing
23K followers
HBF Health, a not-for-profit #health insurance provider, has launched a A$25m ($17.7m) corporate venture fund to invest in health tech #startups. The #CVC fund will invest in early and growth-stage companies, with Sanjeev Gupta as the operational head.
172
12 Comments -
Margaret Davidson
Terrarium • 3K followers
The healthcare workforce is one of four themes we are betting on at Terrarium, where we think technology and AI will catalyze massive changes to the status quo, driving outsized impact on the industry as a whole. We published a white paper today on why building for the future of the healthcare workforce is prime ground for startups, and where we think returns are going to concentrate: https://lnkd.in/e6hsR2VA. Why are we betting on workforce solutions? Simply put, the opportunity is massive. There are not enough healthcare workers across all licensed roles to meet demand, a shortage crisis that will only get worse if nothing is done. Meanwhile, the cost of labor post-Covid--driven primarily by surging contract staffing fees--has become untenable for employers. Labor increased from 50% of hospital OpEx (2011-2019) to 60%+ of hospital OpEx in 2023. These costs are no longer predictable and are eating away at already razor-thin margins in most cases. We have heard from large health systems that contract staffing fees account for over half of recruitment costs, and that total costs of labor shortages are estimated into the hundreds of millions of dollars when accounting for lost revenues alongside direct costs of attrition and replacement. 💸 Healthcare is also the most licensed industry in America, and structural barriers to education and licensure that slow the entry of new professionals into the workforce are a major hurdle to innovation at the top of the talent funnel. We think this hurdle can also act as a defensible moat, however, for companies that do successfully gain traction in this space. 🎓 All to say, we are focused on building and investing in solutions that don't just treat the symptoms, but aim to fix the root cause of the problem: 🌱 Solutions that GROW the workforce, and 🤖 Solutions that OPTIMIZE the work itself If our POV resonates with you, please reach out! We are looking for EIRs to incubate new companies in this space alongside us, and we also write checks to pre-seed and seed teams already on their way. Special thanks for the insights to: Mark Rosenblum, Yaniv Sadka, Austin Dirks, Stephen R. Saine, Hank Capps, MD FAAFP, Laura P. Dannels, PhD, MBA, SPHR, Gabriel Szaszko, Wellstar Health System, Cleveland Clinic, Northwell Health, Mount Sinai Health System, Carl Madi, Lee Hudson Teslik, Alexi Nazem, James Hueston, Rachel Parlier, Raquel Scott, MBA, Zachary Fleitman, Grace Dhanraj, Tanya Beja, Tara Sullivan, Brittany Wadhwani and many others! Company Ventures Terrarium
92
7 Comments -
Eric Berry
Averin • 6K followers
If you’re building at the edge of healthcare innovation, you need to understand how the ground may be shifting beneath you. Averin Capital is hosting a rare conversation between some of the FDA's most influential legal minds of the past 50 years: Peter Hutt - former FDA Chief Counsel and one of the key architects behind the modern food and drug regulatory system. Dan Troy - former FDA Chief Counsel and top advisor to multiple life sciences companies and the U.S. government. Moderated by David Berry, Managing Partner at our firm and one of biotech’s most prolific company builders. They’ll unpack how the FDA’s approach is evolving—and what that means for startups trying to do something new. We’ll cover: • Where regulation is tightening or loosening • How to navigate ambiguity without getting derailed • What smart companies are doing now to get ahead of regulatory risk 🗓 Register here: https://lnkd.in/e-KDH36k This is one of those conversations that doesn’t happen often, but shapes how you think for years. Don’t miss it.
50
2 Comments -
LogicSource, Inc.
18K followers
The trust between advisors and health systems is broken — and both sides are to blame. 🔗 Listen to the full episode: https://lnkd.in/gQ6CB3As Healthcare systems are rejecting transformational opportunities because consultants have overpromised for decades. Meanwhile, gatekeeping middle managers and overwhelmed executives can't afford to take another swing at empty promises. With financial pressures from tariffs and the One Big Beautiful Bill Act ahead, neither side can afford the status quo. In the latest episode of Power Supply Podcast, LogicSource Board Observer and Chair, Healthcare and Life Sciences, Mark Van Sumeren explains why advisors must adopt investment-based selling and get paid on outcomes, not possibilities. Health systems need to triage opportunities better, involve senior leadership directly, and kill underperforming projects fast. 🔗 Learn more about our healthcare practice: https://lnkd.in/gAV-MBer #Healthcare #SupplyChain #HealthcareProcurement
46
1 Comment -
Jessica L. Moon, PhD
The Implementation Group • 2K followers
🍇 𝗚𝗿𝗮𝘁𝗲𝗳𝘂𝗹 (𝘎𝘳𝘢𝘱𝘦𝘧𝘶𝘭 😅) 𝗳𝗼𝗿 𝗮 𝘄𝗼𝗻𝗱𝗲𝗿𝗳𝘂𝗹 𝘄𝗲𝗲𝗸𝗲𝗻𝗱 𝗮𝘁 𝘁𝗵𝗲 𝗕𝗟𝗣𝗡 𝗡𝗮𝗽𝗮 𝗜𝗻𝘃𝗲𝘀𝘁𝗼𝗿 𝗦𝘂𝗺𝗺𝗶𝘁 I was honored to participate in the Non-Dilutive Funding panel alongside an exceptional group of leaders working across foundations, consortia, government programs, and venture—Jill Sorensen (MTEC | Medical Technology Enterprise Consortium), Holly Burkman (BIO Alabama), Sean Drake (Stony Lonesome Group LLC), Eric H. Hanson MD, MPH (MILMED Connect), Greg Grinberg (Origin Foundation Inc). A few takeaways that really stood out 👇🏼 🔹 𝗡𝗼𝗻-𝗱𝗶𝗹𝘂𝘁𝗶𝘃𝗲 𝗰𝗮𝗽𝗶𝘁𝗮𝗹 𝗶𝘀 𝗮𝗯𝗼𝘂𝘁 𝗮𝗹𝗶𝗴𝗻𝗺𝗲𝗻𝘁, 𝗻𝗼𝘁 𝗼𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘀𝗺 The strongest programs reward teams that understand who the sponsor is, what problem they’re solving, and how the work translates to real-world impact — not those chasing every open RFP. 🔹 𝗧𝗵𝗲 𝘃𝗮𝗹𝘂𝗲 𝗶𝘀𝗻’𝘁 𝗷𝘂𝘀𝘁 𝘁𝗵𝗲 𝗱𝗼𝗹𝗹𝗮𝗿𝘀 When integrated thoughtfully, non-dilutive funding can: • De-risk early development • Extend runway by 12–18+ months • Unlock sole-source or follow-on opportunities • Strengthen downstream equity raises 🔹 𝗚𝗿𝗮𝗻𝘁 𝗳𝘂𝗻𝗱𝗶𝗻𝗴 𝗮𝗻𝗱 𝗩𝗖 𝗰𝗮𝗽𝗶𝘁𝗮𝗹 𝗮𝗿𝗲 𝗶𝗻𝗰𝗿𝗲𝗮𝘀𝗶𝗻𝗴𝗹𝘆 𝗰𝗼𝗺𝗽𝗹𝗲𝗺𝗲𝗻𝘁𝗮𝗿𝘆 — 𝗻𝗼𝘁 𝗰𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 From an investor perspective, non-dilutive funding can meaningfully de-risk technical and regulatory milestones, allowing VC dollars to go further and be deployed more strategically. We’re seeing more funds intentionally use blended capital stacks — combining grants, consortia funding, and equity — to extend runway, improve capital efficiency, and ultimately increase impact. 🔹 𝗙𝗲𝗱𝗲𝗿𝗮𝗹 𝗳𝘂𝗻𝗱𝗲𝗿𝘀 𝗹𝗶𝗸𝗲 𝗡𝗜𝗛 𝗮𝗻𝗱 𝗡𝗦𝗙 𝗮𝗻𝗰𝗵𝗼𝗿 𝗹𝗼𝗻𝗴-𝘁𝗲𝗿𝗺 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 While timelines can be longer, they remain essential drivers of biomedical progress. NSF funds significant biomedical and translational work across engineering, computation, and health that 𝘤𝘰𝘮𝘱𝘭𝘦𝘮𝘦𝘯𝘵𝘴 NIH funding—often earlier than private capital can engage. 🔹 𝗢𝗧𝗔𝘀 𝗮𝗻𝗱 𝗰𝗼𝗻𝘀𝗼𝗿𝘁𝗶𝗮 𝗰𝗵𝗮𝗻𝗴𝗲 𝘁𝗵𝗲 𝘀𝗽𝗲𝗲𝗱 𝗲𝗾𝘂𝗮𝘁𝗶𝗼𝗻 Models like MTEC's OTAs demonstrate how companies can move faster than traditional grant pathways and use them to open doors to new opportunities. 𝘛𝘩𝘦 𝘯𝘢𝘮𝘦 𝘰𝘧 𝘵𝘩𝘦 𝘨𝘢𝘮𝘦 𝘪𝘴 𝘱𝘳𝘦𝘱𝘢𝘳𝘢𝘵𝘪𝘰𝘯. HUGE thanks to ✨ Christiaan Engstrom and Caley Anderson, MBA ✨at BLPN for putting this panel together and for recognizing non-dilutive funding as a critical topic in today’s capital-constrained environment. #NonDilutiveFunding #LifeSciences #CapitalStrategy #BLPN #SBIR #OTA #MedTech #Biotech
35
3 Comments
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top content